SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED – Trademark Portfolio

Entity Type: 11

SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AMAKOS. The owner is based in SHIXING COUNTY.

NO. 1 XIN WU SECTION HEBEI VILLAGE, TAI

PING TOWN

SHIXING COUNTY 512500 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AMAKOS
AMAKOS
Registered 2020

Trademark Classifications

SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED have?

SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED file in?

SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 21 (Housewares). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.

What are SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED's most well-known trademarks?

SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED's registered trademark portfolio includes well-known marks such as AMAKOS. These are among 1 currently registered trademark in the portfolio.

What is SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED's trademark registration success rate?

SHAOGUANSHI XIN MEI ORAL CARE PRODUCTS LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.